Seeds of hope: On GM crops and scientific consent

Scientific consent alone should determine availability of products to farmers and consumers

Updated - November 03, 2022 11:35 am IST

Published - November 03, 2022 12:20 am IST

After years of being in limbo, there is a surge of optimism around DMH-11, or Dhara Mustard Hybrid-11, a variety developed using genetic engineering techniques by Indian scientists and public funds. The Genetic Engineering Appraisal Committee (GEAC), the apex regulator and an arm of the Environment Ministry, last week cleared the variety for environmental release. The seed can be grown in fields for producing more of its kind and is a precursor to it being approved for commercial release. DMH-11 employs genes from soil bacterium that makes mustard, a self-pollinating plant, amenable to being crossed with other varieties and producing hybrid varieties. Hybrid varieties are generally more vigorous and, in the case of mustard, an oil seed, will produce more oil. Despite having varieties of mustard, India continues to be a net oil importer due to poor yields. The food crisis due to the Ukraine war has only exacerbated the problem. Despite decades-long trials, mustard hybrids have not made it to Indian farmers because of activists opposed to genetic modification technology in principle and some farmer groups that believe them to be dangerous.

While several top scientists and agricultural experts have cheered the GEAC approval, the celebration ought to be muted. In 2017 too, GEAC had cleared the plant and then did a backtrack by introducing additional tests after protests. In 2009, GEAC had cleared Bt Brinjal, a transgenic food crop, only to be over-ruled by the UPA government — again after protests. Agriculture, being a State subject, may merit political scrutiny before a seed can be commercially released; however, in the case of transgenic technology, these decisions have only served to throttle technological progress. The hold, or the so-called ‘moratorium’, on Bt Brinjal persists and it was only in 2020 that GEAC approved fresh field trials, which were in effect repetitions of earlier tests. It is unclear if it will be available in the immediate future. The barnase-barstar system, used in DMH-11, is promising but already outdated given that cutting-edge technology such as CRISPR is in vogue. DMH-11 alone may not be the panacea for India’s edible oil crisis and rather represents a platform technology that requires seed companies to invest and develop their own hybrids. However, the uncertainty around regulatory policy regarding seed development hinders this. To signal transformation, the Government must second the approval by GEAC and restore the system, whereby scientific consent — rather than political considerations — determines the availability of products to farmers and consumers.

To read this editorial in Hindi, click here.

To read this editorial in Tamil, click here.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.